News & Updates
Filter by Specialty:
Show Multimedia Only

Bispecific antibody delivers positive results in relapsed, refractory multiple myeloma
08 Jun 2024
byJairia Dela Cruz
A large percentage of patients with relapsed/refractory multiple myeloma (RRMM) respond to the bispecific antibody linvoseltamab, with deep and durable responses seen even in the high-risk subgroups, according to data from the phase I/II LINKER-MM1 trial.
Bispecific antibody delivers positive results in relapsed, refractory multiple myeloma
08 Jun 2024
Bariatric surgery helps improve outcomes in IBD
07 Jun 2024
byStephen Padilla
Bariatric surgery (BS), particularly sleeve gastrectomy, contributes to the improvement of disease-specific outcomes in patients with inflammatory bowel disease (IBD) and obesity, reports a study.
Bariatric surgery helps improve outcomes in IBD
07 Jun 2024
ART discontinuation tied to toxicity, disease progression in mCRPC patients
07 Jun 2024
Several patients with metastatic castration-resistant prostate cancer (mCRPC) discontinue the use of androgen receptor‒targeted therapies (ARTs) because of disease progression, while a few stopped ARTs due to treatment toxicity, according to a study.